logo

CRNX

Crinetics·NASDAQ
--
--(--)
--
--(--)
3.09 / 10
Netural

Financial evaluation shows constrained fundamentals, scoring 3.1/10. Key concerns include Total Operating Revenue and Operating Revenue YoY growth both at 47.7%, which historically underperform, while Interest Coverage Ratio at 15.5% offers some cushion. Metrics like Days Sales Outstanding at 72.5 days and negative Revenue-MV suggest working capital inefficiencies and valuation discount. Overall, the balance sheet and profitability remain subdued, warranting caution.

Fundamental(3.09)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-8.05
Score1/3
Weight8.92%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value47.74
Score1/3
Weight-1.30%
1M Return-0.79%
Days sales outstanding
Value72.55
Score1/3
Weight-2.44%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight17.72%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight17.74%
1M Return8.45%
PB-ROE
Value2.19
Score2/3
Weight22.10%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.77%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value47.74
Score1/3
Weight-1.25%
1M Return-0.76%
Asset-MV
Value-0.50
Score2/3
Weight22.85%
1M Return10.15%
Cash-MV
Value-0.07
Score2/3
Weight17.42%
1M Return8.41%
Is CRNX fundamentally strong?
  • CRNX scores 3.09/10 on fundamentals and holds a Fair valuation at present. Backed by its -28.58% ROE, -27563.32% net margin, -12.55 P/E ratio, 4.33 P/B ratio, and -22.43% earnings growth, these metrics solidify its Netural investment rating.